Skip to content

Comparison of successes and complications of inpatient and outpatient treatment in the second trimester abortion with misoprostol

Comparison of successes and complications of inpatient and outpatient treatment in the second trimester abortion with misoprostol

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220305054197N1
Enrollment
140
Registered
2022-06-11
Start date
2021-03-21
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: abortion. Condition 2: abortion. Induction of abortion in the second trimester as an outpatient with misoprostol Induction of abortion in the second trimester as an inpatient with misoprostol

Interventions

Intervention 1: first Intervention group: inpatient- Each patient is given misoprostol(MISOGLANDIN made in SAMI SAZ co. ) at a dose of 600 micrograms sublingually and then every 6 hours for 400 microg

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Pregnant woman with indication of abortion in the second trimester of pregnancy , stable hemodynamic conditions Patients living with the family Ability to move quickly to the hospital

Exclusion criteria

Exclusion criteria: The presence of heart, lung, kidney, liver disease Uncontrolled seizures Hemoglobin is less than 10 IUD in the womb Coagulation disorder severe bleeding fever or signs of infectious abortion Misoprostol sensitivity

Design outcomes

Primary

MeasureTime frame
The success rate of spontaneous abortion with misoprostol administration (no need for curettage). Timepoint: After intervention up to 2 weeks. Method of measurement: Questionnaire and ultrasound to evaluation of fetal and placental abortion.;Need for blood transfusion. Timepoint: After intervention up to 2 weeks. Method of measurement: base on CBC test.;Infection. Timepoint: After intervention up to 2 weeks. Method of measurement: history and physical examination and ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVida Valehi

Mashhad University of Medical Sciences

Valehiv971@mums.ac.ir+98 51 3605 4155

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026